- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x ARG: ARGININE(Non-covalent)
ARG.2: 15 residues within 4Å:- Chain A: Y.98, T.102, R.105, N.133, D.134, R.137, S.186, R.187, Y.193, S.195, E.197, E.271, Y.283, Y.323
- Ligands: ANP.1
18 PLIP interactions:17 interactions with chain A, 1 Ligand-Ligand interactions- Hydrophobic interactions: A:T.102, A:Y.283
- Hydrogen bonds: A:Y.98, A:Y.98, A:R.105, A:N.133, A:S.186, A:E.271
- Water bridges: A:N.133, A:D.134, A:R.187, A:D.188, A:D.188, R.2
- Salt bridges: A:D.134, A:R.137, A:D.188, A:E.197
ARG.12: 16 residues within 4Å:- Chain B: Y.98, T.102, R.105, N.133, D.134, R.137, S.186, R.187, D.188, Y.193, S.195, E.197, E.271, Y.283, Y.323
- Ligands: ANP.11
16 PLIP interactions:16 interactions with chain B,- Hydrophobic interactions: B:T.102, B:Y.283
- Hydrogen bonds: B:Y.98, B:Y.98, B:R.105, B:N.133, B:S.186, B:E.271
- Water bridges: B:D.134, B:D.134, B:R.187, B:R.187
- Salt bridges: B:D.134, B:R.137, B:D.188, B:E.197
ARG.20: 16 residues within 4Å:- Chain C: Y.98, T.102, R.105, N.133, D.134, R.137, S.186, R.187, D.188, Y.193, S.195, E.197, E.271, Y.283, Y.323
- Ligands: ANP.19
16 PLIP interactions:13 interactions with chain C, 3 Ligand-Ligand interactions- Hydrophobic interactions: C:T.102, C:Y.283
- Hydrogen bonds: C:T.102, C:R.105, C:N.133, C:S.186, C:E.271, C:Y.323, R.20, R.20
- Water bridges: C:R.187, R.20
- Salt bridges: C:D.134, C:R.137, C:D.188, C:E.197
ARG.29: 16 residues within 4Å:- Chain D: Y.98, T.102, R.105, N.133, D.134, R.137, S.186, R.187, D.188, Y.193, S.195, E.197, E.271, Y.283, Y.323
- Ligands: ANP.28
18 PLIP interactions:15 interactions with chain D, 3 Ligand-Ligand interactions- Hydrophobic interactions: D:T.102, D:Y.283
- Hydrogen bonds: D:T.102, D:R.105, D:N.133, D:S.186, D:E.271, D:Y.283, D:Y.323, R.29, R.29
- Water bridges: D:D.134, D:R.187, R.29
- Salt bridges: D:D.134, D:R.137, D:D.188, D:E.197
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
MG.3: 1 residues within 4Å:- Ligands: ANP.1
No protein-ligand interaction detected (PLIP)MG.13: 1 residues within 4Å:- Ligands: ANP.11
No protein-ligand interaction detected (PLIP)MG.21: 1 residues within 4Å:- Ligands: ANP.19
No protein-ligand interaction detected (PLIP)MG.30: 1 residues within 4Å:- Ligands: ANP.28
No protein-ligand interaction detected (PLIP)- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 3 residues within 4Å:- Chain A: Y.71, V.72
- Ligands: EDO.5
Ligand excluded by PLIPEDO.5: 4 residues within 4Å:- Chain A: K.69, A.70, Y.71
- Ligands: EDO.4
Ligand excluded by PLIPEDO.6: 3 residues within 4Å:- Chain A: H.365, S.366, P.367
Ligand excluded by PLIPEDO.8: 4 residues within 4Å:- Chain A: Q.405, Q.408
- Chain B: P.147, Q.148
Ligand excluded by PLIPEDO.9: 3 residues within 4Å:- Chain A: P.147, Q.148
- Chain B: Q.405
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: T.304, R.305, S.306
- Chain C: S.399, A.400
- Chain D: Y.140
Ligand excluded by PLIPEDO.14: 4 residues within 4Å:- Chain B: K.59, K.69, A.70, Y.71
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain B: H.365, S.366, P.367
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain B: Q.110, V.113, E.114, L.145
Ligand excluded by PLIPEDO.17: 6 residues within 4Å:- Chain B: T.304, R.305, S.306
- Chain C: Y.140
- Chain D: S.399, A.400
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain A: S.399, A.400
- Chain B: Y.140
- Chain C: T.304, R.305, S.306
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain C: A.70, Y.71, V.72
- Ligands: EDO.23
Ligand excluded by PLIPEDO.23: 2 residues within 4Å:- Chain C: A.70
- Ligands: EDO.22
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain C: H.365, S.366, P.367
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain C: Q.405
- Chain D: P.147, Q.148
Ligand excluded by PLIPEDO.26: 3 residues within 4Å:- Chain C: P.147, Q.148
- Chain D: Q.405
Ligand excluded by PLIPEDO.27: 6 residues within 4Å:- Chain A: Y.140
- Chain B: S.399, A.400
- Chain D: T.304, R.305, S.306
Ligand excluded by PLIPEDO.31: 4 residues within 4Å:- Chain D: K.59, K.69, A.70, Y.71
Ligand excluded by PLIPEDO.32: 3 residues within 4Å:- Chain D: H.365, S.366, P.367
Ligand excluded by PLIPEDO.33: 4 residues within 4Å:- Chain A: L.314, T.317
- Chain D: L.310, S.313
Ligand excluded by PLIP- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J.A. et al., Crystal Structure of Argininosuccinate synthase from Legionella pneumophila Philadelphia 1 in complex with ANPPNP and a substrate analogue Arginine. to be published
- Release Date
- 2020-09-30
- Peptides
- Argininosuccinate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.85 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)
- 4 x ARG: ARGININE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-functional Binders)
- 20 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x ACT: ACETATE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Abendroth, J.A. et al., Crystal Structure of Argininosuccinate synthase from Legionella pneumophila Philadelphia 1 in complex with ANPPNP and a substrate analogue Arginine. to be published
- Release Date
- 2020-09-30
- Peptides
- Argininosuccinate synthase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D